Teosyal Puresense REDENSITY I stands at the intersection of dermal fillers and mesotherapy. It is made of non-crosslinked hyaluronic acid combined with a Dermo-Restructuring Complex. Its purpose is dermis redensification, and it is intended for administration into the superficial to mid-dermis. Dermal filler Teosyal REDENSITY I contains Lidocaine, so any pain or discomfort will be minimal.
Dermal filler Teosyal REDENSITY I is used for redensifying and deeply rehydrating the skin. It is highly suitable for wrinkle prevention on younger skin but can also be used for treating signs of aging on more mature skin. Dermal filler Teosyal REDENSITY I has a patented formulation which includes hyaluronic acid as an intensive hydrating agent, plus vitamin B6, zinc, copper, eight essential amino acids, and the antioxidants glutathione, N-acetyl-L-cysteine, and alpha-lipoic acid.
Dermal filler Teosyal REDENSITY I is indicated for rehydrating the skin and can be applied to the face, the décolletage, and the neck. It can be used to combat indications of aging, whether these be premature, the result of too much sun exposure, or simply due to the passage of time. Skin takes on a healthy glow and new firmness as a result of treatment. It is recommended that Teosyal REDENSITY I be administered three times at three week intervals and that the patient return for maintenance sessions every four to six months.
Dermal filler Teosyal REDENSITY I is composed of non-crosslinked hyaluronic acid along with a Dermo-Restructuring Complex consisting of eight amino acids, three antioxidants, two minerals, and one vitamin. Each package contains two syringes prefilled with 1 ml of gel and accompanied by two 30G x 1/2” needles. The concentration of Lidocaine is 3 mg/ml, while that of the hyaluronic acid is 15 mg/ml. Teosyal Puresense REDENSITY I is manufactured by Teoxane Laboratories in Switzerland.